Technology Prognosis

tracking technologies before you have to make a decision

Elzonris (Tagraxofusp-erzs) for BPDCN

May 3, 2019

Elzonris is a recombinant protein consisting of human interleukin-3 (IL-3) conjugated with diphtheria toxin that is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm. This protein binds to the IL-3 receptor subunit alpha chain (CD123), preventing protein synthesis and prompting cell death.